Explore evidence

28.8 monthsThe median follow-up duration among HIV-2-infected individuals initiating antiretroviral therapy was 28.8 months.

Côte d'IvoireVIH/sidapublished 2016AIDS (London, England)europe_pmcdocument of 6 observations

24.1 %Among females, malaria prevalence was 24.1%.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

77 %HIV RNA less than 50 copies/ml at 24 weeks was observed in 24 of 31 (77%) patients in the ZDV arm.

Côte d'IvoireVIH/sidapublished 2017AIDS (London, England)europe_pmcdocument of 7 observations

A cluster-randomised controlled trial demonstrated a significant reduction in malaria incidence and prevalence following a larviciding campaign using a granular formulation of the insect growth regulator pyriproxyfen in a gem mining setting.

Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations

0.13 %Triple mixed infection of Plasmodium falciparum, Plasmodium malariae, and Plasmodium ovale accounted for 0.13% of 2246 identified Plasmodium species.

Côte d'IvoirePlasmodium falciparum + Plasmodium malariae + Plasmodium ovaleHAL · Unilimdocument of 122 observations

67.6 %Of 216 reported clinical indicators among 273 patients, 146 (67.6%) were reported without HIV test proposal and thus constituted missed opportunities.

Côte d'IvoireVIH/sidaobserved 2013–2014published 2017PloS oneeurope_pmcdocument of 5 observations

13.9 %The prevalence of malaria cases detected by RDTs was 13.9% in Survey 1.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

13 patientsDuring 34 months of follow-up, 13 patients (21%) received second-line treatment.

Côte d'IvoireVIH/sidaobserved 34 monthspublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

67.8 %67.8% of patients had AIDS.

Côte d'IvoireVIH/sidapublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

2.5 %65 (2.5%) of 2611 participants had raised alanine aminotransferase.

Côte d'Ivoireliver injurypublished 2021The lancet. HIVeurope_pmcdocument of 5 observationsDOI 10.1016/s2352-3018(20)30299-x

2,407 patientsIn Mali, Cameroon, and Ivory Coast, 2407 sickle cell disease patients aged 3 years old and over were included in the study.

Cameroun · Côte d'Ivoire · Malidrépanocytosepublished 2017Bloodeurope_pmcdocument of 4 observationsDOI 10.1182/blood-2016-12-755777

5.5 log_copies/mLThe median HIV RNA level was 5.5 log copies/mL.

Côte d'IvoireVIH/sidapublished 2024Open forum infectious diseaseseurope_pmcdocument of 9 observations

67.5 %54 patients (67.5%) were naive of antiretroviral treatment, with a mean CD4 count of 45/mm³.

Côte d'IvoireVIH/sidaobserved 2005-2008published 2012Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

80 patientsEighty patients presenting with cryptococcal meningitis were included, representing 2.6% of hospitalized patients at Treichville University Hospital between January 1, 2005 and December 31, 2008.

Côte d'Ivoireméningite cryptococciqueobserved 2005-2008published 2012Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

472 per_mm3Median CD4+ cell count was 472/mm³ among enrolled HIV-infected adult patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'IvoireVIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

12 monthsPre-ART sVCAM-1 levels significantly decreased after 12 months of ART.

Côte d'IvoireVIH/sidapublished 2022HIV medicineeurope_pmcdocument of 6 observations

52 %The proportion of Pfcrt-76T mutant allele was 52% in patients less than 5 years old in Abobo, Ivory Coast.

Côte d'Ivoirepaludismeobserved 2009published 2019Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 5 observations

8 %Chez 8 % des femmes dépistées lors de la Caravane de l'Espoir en Côte d'Ivoire en 2014, une pathologie (bénigne ou maligne) aurait été décelée.

Côte d'Ivoirepathologieobserved 2014HAL · Unilimdocument of 81 observations

70 %Detectable HCV RNA was identified in 70.0% of anti-HCV positive patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

36 monthsPatients were followed for a median 36 months in a prospective cohort study of antiretroviral-naïve HIV-HBV co-infected patients from Côte d'Ivoire.

Côte d'IvoireHIV-HBVpublished 2018Journal of viral hepatitiseurope_pmcdocument of 7 observationsDOI 10.1111/jvh.12914

1,000,000 deathsTuberculosis was responsible for more than one million deaths in 2018.

Côte d'Ivoiretuberculoseobserved 2018published 2022Revue d'epidemiologie et de sante publiqueeurope_pmcdocument of 5 observations

7 %Among hospitalized HIV-positive adults in West Africa who died, the underlying cause of death was other diseases in 7% of cases.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

51.1 %Only 51.1% of the AEB victims were correctly vaccinated against hepatitis B.

Côte d'Ivoirehépatite Bobserved January 2000 to December 2005published 2007Medecine et maladies infectieuseseurope_pmcdocument of 11 observations

3 patientsHypertriglyceridaemia was present in all three patients.

Côte d'Ivoirehypertriglyceridemiapublished 2009Antiviral therapyeurope_pmcdocument of 11 observations

156 per_1000_person_yearsThe mean weekly malaria incidence over the year for the entire population was equivalent to 156 cases per 1000 person-years.

Côte d'Ivoirepaludismeobserved August 31, 2016–August 31, 2017HAL · Unilimdocument of 122 observations